send to a friend by email
2024-06-12
According to the financial statements of Birzeit Pharmaceuticals Company BPC for the 1st Quarter of 2024, Net Loss after tax of the period reached (1,465,919) USD Compared with Net profit after tax 1,794,391 USD for 2023.Total assets of the company reached 120,967,518 USD compared with total assets of 125,146,969 USD at the end of year 2023, a net decrease of 3.34%.Total liabilities of the company reached 19,973,815 USD compared with total liabilities of 20,122,207 USD at the end of year 2023, a net decrease of 0.73%. Net ownership equity of the company reached 100,993,703 USD (Including Non-Controlling Interests of 641,185 USD) compared with total owner equity of 105,024,762 USD (Including Non-Controlling Interests of 700,373 USD) at the end of year 2023, a net decrease of 3.84%.
|
|